Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Preferred Stock Liabilities (2019 - 2020)

Silo Pharma's Preferred Stock Liabilities history spans 2 years, with the latest figure at $400000.0 for Q2 2020.

  • For Q2 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $400000.0; the TTM value through Jun 2020 reached $400000.0, changed 0.0%, while the annual FY2019 figure was $400000.0, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q2 2020 was $400000.0 at Silo Pharma, roughly flat from $400000.0 in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $400000.0 in Q1 2019 and bottomed at $400000.0 in Q1 2019.